Form 3 - Initial statement of beneficial ownership of securities:
SEC Accession No. 0001708599-25-000060
Filing Date
2025-06-17
Accepted
2025-06-17 20:20:57
Documents
1
Period of Report
2025-05-22

Document Format Files

Seq Description Document Type Size
1 FORM 3 wk-form3_1750206050.html 3  
1 FORM 3 wk-form3_1750206050.xml 3 1579
  Complete submission text file 0001708599-25-000060.txt   3156
Mailing Address 601 GENOME WAY SUITE 2001 HUNTSVILLE AL 35806
Business Address 601 GENOME WAY SUITE 2001 HUNTSVILLE AL 35806 (256) 327-9630
Serina Therapeutics, Inc. (Issuer) CIK: 0001708599 (see all company filings)

EIN.: 821436829 | State of Incorp.: AL | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)

Mailing Address C/O KARUNA THERAPEUTICS, INC. 33 ARCH STREET, SUITE 3110 BOSTON MA 02110
Business Address
Brannan Stephen K. (Reporting) CIK: 0001777631 (see all company filings)

Type: 3 | Act: 34 | File No.: 001-38519 | Film No.: 251054889